1. VieiraP, RajewskyK (1988) The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 18: 313–316.
2. YuX, TsibaneT, McGrawPA, HouseFS, KeeferCJ, et al. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455: 532–526.
3. SlifkaMK, AntiaR, WhitmireJK, AhmedR (1998) Humoral immunity due to long-lived plasma cells. Immunity 8: 363–372.
4. RadbruchA, MuehlinghausG, LugerEO, InamineA, SmithKGC, et al. (2006) Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6: 741–750.
5. NduatiEW, NgDHL, NdunguFM, GardnerP, UrbanBC, et al. (2010) Distinct Kinetics of Memory B-Cell and Plasma-Cell Responses in Peripheral Blood Following a Blood-Stage Plasmodium chabaudi Infection in Mice. PLoS One 5: e15007.
6. GreenwoodBM (1974) Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet 303: 435–436.
7. CadmanET, AbdallahAY, VoisineC, SponaasAM, CorranP, et al. (2008) Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect Immun 76: 3924–3931.
8. AchtmanAH, StephensR, CadmanET, HarrisonV, LanghorneJ (2007) Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol 29: 435–444.
9. LooareesuwanS, HoM, WattanagoonY, WhiteNJ, WarrellDA, et al. (1987) Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med 317: 675–679.
10. WykesMN, ZhouYH, LiuXQ, GoodMF (2005) Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol 175: 2510–2516.
11. Strambachová-McBrideJ, MicklemHS (1979) Immunosuppression in murine malaria. IV. The secondary response to bovine serum albumin. Parasite Immunol 1: 141–157.
12. RadwanskaM, GuirnaldaP, De TrezC, RyffelB, BlackS, et al. (2008) Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog 4: e1000078.
13. XiangZ, CutlerAJ, BrownlieRJ, FairfaxK, LawlorKE, et al. (2007) FcγRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8: 419–429.
14. GoumardP, VuDN, MauroisP, CamusD (1982) Influence of malaria on a pre-existing antibody response to heterologous antigens. Ann Immunol (Paris) 133: 313–326.
15. AmannaIJ, CarlsonNE, SlifkaMK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357: 1903–1915.
16. KassiotisG, GrayD, KiafardZ, ZwirnerJ, StockingerB (2006) Functional specialization of memory Th cells revealed by expression of integrin CD49b. J Immunol 177: 968–975.
17. FlynnKJ, BelzGT, AltmanJD, AhmedR, WoodlandDL, et al. (1998) Virus-Specific CD8+ T Cells in Primary and Secondary Influenza Pneumonia. Immunity 8: 683–691.
18. OdendahlM, MeiH, HoyerBF, JacobiAM, HansenA, et al. (2005) Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105: 1614–1621.
19. ClatworthyMR, WillcocksL, UrbanB, LanghorneJ, WilliamsTN, et al. (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcγRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A 104: 7169–7174.
20. TraggiaiE, PuzoneR, LanzavecchiaA (2003) Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21: S35–S37.
21. BernasconiNL, OnaiN, LanzavecchiaA (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500–4504.
22. BernasconiNL, TraggiaiE, LanzavecchiaA (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199–2202.
23. GongQ, OuQ, YeS, LeeWP, CorneliusJ, et al. (2005) Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy. J Immunol 174: 817–826.
24. AhujaA, ShupeJ, DunnR, KashgarianM, KehryMR, et al. (2007) Depletion of B cells in murine lupus: efficacy and resistance. J Immunol 179: 3351–3361.
25. AhujaA, AndersonSM, KhalilA, ShlomchikMJ (2008) Maintenance of the plasma cell pool is independent of memory B cells. Proc Natl Acad Sci U S A 105: 4802–4807.
26. DiLilloDJ, HamaguchiY, UedaY, YangK, UchidaJ, et al. (2008) Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 180: 361–371.
27. MoserK, TokoyodaK, RadbruchA, MacLennanI, ManzRA (2006) Stromal niches, plasma cell differentiation and survival. Curr Opin Immunol 18: 265–270.
28. SzeDMY, ToellnerKM, de VinuesaCG, TaylorDR, MacLennanI (2000) Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 192: 813–821.
29. TerstappenLW, JohnsenS, Segers-NoltenIM, LokenMR (1990) Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood 76: 1739–1747.
30. FairfaxKA, KalliesA, NuttSL, TarlintonDM (2008) Plasma cell development: from B-cell subsets to long-term survival niches. Semin Immunol 20: 49–58.
31. VezysV, YatesA, CaseyKA, LanierG, AhmedR, et al. (2008) Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196–199.
32. VikiB, NathalieG (2011) Acute Disruption of Bone Marrow B Lymphopoiesis and Apoptosis of Transitional and Marginal Zone B Cells in the Spleen following a Blood-Stage Plasmodium chabaudi Infection in Mice. J Parasitol Res 2011: 534697.
33. TokoyodaK, EgawaT, SugiyamaT, ChoiBI, NagasawaT (2004) Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20: 707–718.
34. StephensR, NdunguFM, LanghorneJ (2009) Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells. Parasite Immunol 31: 20–31.
35. MaruyamaM, LamKP, RajewskyK (2000) Memory B-cell persistence is independent of persisting immunizing antigen. Nature 407: 636–642.
36. TomaykoMM, AndersonSM, BraytonCE, SadanandS, SteinelNC, et al. (2008) Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities. J Immunol 181: 27–38.
37. CrottyS, FelgnerP, DaviesH, GlidewellJ, VillarrealL, et al. (2003) Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171: 4969–4973.
38. BensonMJ, DillonSR, CastigliE, GehaRS, XuS, et al. (2008) Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J Immunol 180: 3655–3659.
39. Mamani-MatsudaM, CosmaA, WellerS, FailiA, StaibC, et al. (2008) The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 111: 4653–4659.
40. BensonMJ, ElguetaR, SchperoW, MolloyM, ZhangW, et al. (2009) Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 206: 2013–2025.
41. Dal PortoJM, HabermanAM, KelsoeG, ShlomchikMJ (2002) Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced. J Exp Med 195: 1215–1221.
42. TarlintonDM, SmithKGC (2000) Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol Today 21: 436–441.
43. Jelley-GibbsDM, BrownDM, DibbleJP, HaynesL, EatonSM, et al. (2005) Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med 202: 697–706.
44. HebeisBJ, KlenovsekK, RohwerP, RitterU, SchneiderA, et al. (2004) Activation of virus-specific memory B cells in the absence of T cell help. J Exp Med 199: 593–602.
45. KlenovsekK, WeiselF, SchneiderA, AppeltU, JonjicS, et al. (2007) Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 110: 3472–3479.
46. OnoderaT, TakahashiY, YokoiY, AtoM, KodamaY, et al. (2012) Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc Natl Acad Sci U S A 109: 2485–2490.
47. GreenwoodBM, WhittleHC, BradleyAK, FayetMT, GillesHM (1980) The duration of the antibody response to meningococcal vaccination in an African village. Trans R Soc Trop Med Hyg 74: 756–760.
48. AbdurrahmanMB, GreenwoodBM, OlafimihanO, WhitleHC (1982) Measles antibody levels from birth to 9 months of age in Nigerian infants. Afr J Med Med Sci 11: 113–115.
49. HanlonP, HanlonL, MarshV, ByassP, SillahH, et al. (1987) Serological comparisons of approaches to polio vaccination in the Gambia. Lancet 1: 800–801.
50. SchellenbergA (2000) Humoral immune responses during a malaria vaccine trial in Tanzanian infants. Parasite Immunol 22: 437–443.
51. WilliamsonWA, GreenwoodBM (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 311: 1328–1329.
52. TempleK, GreenwoodB, InskipH, HallA, KoskelaM, et al. (1991) Antibody response to pneumococcal capsular polysaccharide vaccine in African children. Pediatr Infect Dis J 10: 386–390.
53. MacLennanJ, ObaroS, DeeksJ, LakeD, ElieC, et al. (2001) Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J Infect Dis 183: 97–104.
54. CampbellH, ByassP, AhonkhaiVI, VellaPP, GreenwoodBM (1990) Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 86: 102–107.
55. CuttsFT, ZamanSMA, EnwereG, JaffarS, LevineOS, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139–1146.
56. HollandWG, DoTT, HuongNT, DungNT, ThanhNG, et al. (2003) The effect of Trypanosoma evansi infection on pig performance and vaccination against classical swine fever. Vet Parasitol 111: 115–123.
57. RurangirwaFR, MusokeAJ, NantulyaVM, TabelH (1983) Immune depression in bovine trypanosomiasis: effects of acute and chronic Trypanosoma congolense and chronic Trypanosoma vivax infections on antibody response to Brucella abortus vaccine. Parasite Immunol 5: 267–276.
58. SharpeRT, LangleyAM, MowatGN, MacaskillJA, HolmesPH (1982) Immunosuppression in bovine trypanosomiasis: response of cattle infected with Trypanosoma congolense to foot-and-mouth disease vaccination and subsequent live virus challenge. Res Vet Sci 32: 289–293.
59. WhitelawDD, ScottJM, ReidHW, HolmesPH, JenningsFW, et al. (1979) Immunosuppression in bovine trypanosomiasis: studies with louping-ill vaccine. Res Vet Sci 26: 102–107.
60. MwangiDM, MunyuaWK, NyagaPN (1990) Immunosuppression in caprine trypanosomiasis: effects of acute Trypanosoma congolense infection on antibody response to anthrax spore vaccine. Trop Anim Health Prod 22: 95–100.
61. ShinkaiY, RathbunG, LamKP, OltzEM, StewartV, et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement. Cell 68: 855–867.
62. BorossP, ArandharaVL, Martin-RamirezJ, Santiago-RaberML, CarlucciF, et al. (2011) The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J Immunol 187: 1304–1313.
63. Ioan-FacsinayA, De KimpeSJ, HellwigSMM, Van LentPL, HofhuisFMA, et al. (2002) FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16: 391–402.
64. SladeSJ, LanghorneJ (1989) Production of Interferon-Gamma during Infection of Mice with Plasmodium chabaudi chabaudi. Immunobiology 179: 353–365.
65. LanghorneJ, GillardS, SimonB, SladeS, EichmannK (1989) Frequencies of CD4+ T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol 1: 416–424.
66. HaY, StevensDJ, SkehelJJ, WileyDC (2002) H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J 21: 865–875.
67. BlackmanMJ, Scott-FinniganTJ, ShaiS, HolderAA (1994) Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med 180: 389–393.
68. KaviratneM, KhanSM, JarraW, PreiserPR (2002) Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells. Eukaryot Cell 1: 926–935.
69. AntunesI, KassiotisG (2010) Suppression of innate immune pathology by regulatory T cells during influenza A virus infection of immunodeficient mice. J Virol 84: 12564–12575.
70. WardCL, DempseyMH, RingCJA, KempsonRE, ZhangL, et al. (2004) Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 29: 179–188.
71. QuinSJ, LanghorneJ (2001) Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses. Infect Immun 69: 2245–2251.
72. CrottyS, AubertRD, GlidewellJ, AhmedR (2004) Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286: 111–122.
73. NdunguFM, CadmanET, CoulcherJ, NduatiE, CouperE, et al. (2009) Functional Memory B Cells and Long-Lived Plasma Cells Are Generated after a Single Plasmodium chabaudi Infection in Mice. PLoS Pathog 5: e1000690.